 |
 |
|
|
 |
|
|
 |
|
 |
|
|
Oncology
Summit Europe
30th
January - DAY ONE
8.20
AM |
Pre-conference
registration and light breakfast |
9.20
AM |
Chairman's
opening remarks
Sean McGrath, Managing
Director, Succinct Healthcare Communications
and Consultancy |
|
|
Address
The Patient Challenges
|
9.30
AM
|
Cancer
Care in Europe – a Patchwork of Provision Across
a Continent
Prof
Karol Sikora, Medical Director,
Cancer Patients UK |
10.10
AM
|
Collaborate
Effectively with Patient Groups
Jola
Gore-Booth, Chief Executive,
europacolon |
10.50
AM |
Networking
Break & Exhibition (40 minutes) |
|
Pricing,
Access and Reimbursement
|
11.30
AM |
Budget
Impact Models or Cost-Effective Analysis?
Eddie
Gibson, Business Unit Director,
Oncology , BMS |
12.10
PM |
Market
Access and Managed Entry with Oncology Drugs
in Europe
Chris
Teale, Director,
Global Pricing and Market
Access Strategy , AstraZeneca |
12.50
PM |
Networking
Lunch & Exhibition (1 hour 10 minutes) |
2.00
PM |
Key
Success Factors for Launching Oncology Products
in Europe
Nader
Naeymi-Rad, Senior Vice President,
Brand Management Practice, Campbell
Alliance |
2.40PM
|
Pricing
for Outcome and Risk Sharing: How Should Pharma
React Next?
Uday
Bose, European Marketing Director,
GSK |
3.20
PM |
Break
& Exhibition (30 minutes) |
|
3.50
PM |
New
Targeted Drugs or Newer Niche Indications –
Who Benefits, Who Pays?
John
De Wit, Business Unit Director,
Oncology, Amgen
|
| |
Marketing
Best Practice in Oncology
|
4.30
PM |
Is
Oncology Marketing a Special Case? How can we
Adopt a Leadership Position?
Gary
Hendler , Associate VP, Oncology
Marketing , sanofi-aventis |
5:10
PM |
End
of Day One Questions and Chairman's Closing
Remarks |
31st
January- DAY TWO
9.00
AM |
Introduction
to Day Two
Sean
McGrath, Managing Director,
Succinct Healthcare Communications and
Consultancy |
| |
Working
with Healthcare and Service Providers
|
9.10
AM |
Work
in Partnership with Government and Healthcare
Providers to Improve Patient Access to Cancer
Medicines
Jackie
Holding , Consultant, Holding
Associates |
|
9.50
AM |
Discover
the Most Innovative Emerging Local and Regional
Cancer Therapy Devices
Crispin
Simon, CEO, Biocompatibles
|
10.30
AM |
Networking
Break & Exhibition (40 minutes) |
11.10
AM |
Oncology
Trends and Future Challenges and Opportunities
Graham
Lewis, VP Europe, Global Pharma
Strategy, IMS |
11.50
AM |
The
Patient of 2020: A Look At Cancer Care In The
Near Future
Prof
Gordon McVie, Senior Consultant
, European Institute of Oncology
|
12.30
AM |
Special
Question Time Session
Hosted
by: Prof Gordon McVie , Senior
Consultant, European Institute
of Oncology |
1.15
PM |
Lunch
& Exhibition (1 hour) |
2:15
PM |
CLOSE
OF CONFERENCE |
|
|
 |
Global Sponsor: |
|
|
|
Gold Sponsor: |
|
|
|
Gold Exhibitor: |
|
|
|
Silver Exhibitor: |
|
|
|
Media Partners: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|